A 24-year-old woman presents to the emergency department with a 3-day history of lower abdominal pain and vaginal discharge. She is sexually active with multiple partners and has not used barrier contraception. On bimanual pelvic examination, the structure marked **A** is elicited — the patient winces and jumps when the cervix is moved during the examination. Her temperature is 38.5°C. Cervical swabs are sent for nucleic acid amplification testing. Based on the clinical findings, which of the following is the most appropriate empiric antibiotic regimen according to CDC 2021 guidelines for outpatient management?

## Why Ceftriaxone 500 mg IM + Doxycycline + Metronidazole is right The structure marked **A** — cervical motion tenderness (CMT, or "chandelier sign") — is a classic minimum criterion for pelvic inflammatory disease (PID) according to CDC guidelines. When a sexually active woman with lower abdominal pain and fever presents with CMT, empiric treatment for PID is indicated without awaiting culture results. The CDC 2021 outpatient regimen specifically mandates ceftriaxone 500 mg IM single dose (covering *Neisseria gonorrhoeae*) plus doxycycline 100 mg PO BID × 14 days (covering *Chlamydia trachomatis*) plus metronidazole 500 mg PO BID × 14 days (covering anaerobes and gram-negative enteric flora). This triple-agent approach addresses the polymicrobial nature of ascending PID and is the standard of care for outpatient management in India and globally. ## Why each distractor is wrong - **Cefotetan IV + Doxycycline IV × 14 days**: This is an inpatient regimen reserved for severe PID, pregnancy, IUD-associated infection, tubo-ovarian abscess, failed outpatient therapy, or inability to tolerate oral medications. The patient in this scenario is stable enough for outpatient management. - **Amoxicillin-clavulanate 625 mg PO TID × 7 days**: This regimen is inadequate for PID. It does not reliably cover *Neisseria gonorrhoeae* or *Chlamydia trachomatis*, the two most common sexually transmitted pathogens in PID, and the 7-day duration is insufficient (CDC recommends 14 days minimum). - **Ciprofloxacin 500 mg PO BID × 10 days**: Fluoroquinolones are no longer recommended for gonorrhea due to widespread resistance. Additionally, ciprofloxacin monotherapy does not provide adequate coverage for the polymicrobial flora in PID, and 10 days is shorter than the recommended 14-day course. **High-Yield:** Cervical motion tenderness is a CDC minimum criterion for empiric PID treatment; outpatient regimen = ceftriaxone IM + doxycycline PO + metronidazole PO × 14 days. [cite: Williams Gynecology 4e; CDC STI Guidelines 2021]